IL1A and synovial sarcoma: The etiology of SS remains largely unknown but is thought to involve aberrant neutrophils2; genetic factors2; and proinflammatory cytokines such as IL-1, TNF-α, and IL-6.1–3 Although systemic steroids effectively treat many patients with SS, there is a pressing need for novel therapeutic approaches to address steroid resistance and minimize side effects.